{"hands_on_practices": [{"introduction": "The challenge of detecting circulating tumor DNA (ctDNA) is often described as finding a \"needle in a haystack.\" This exercise provides a quantitative foundation for that analogy by converting commonly reported clinical values, such as cell-free DNA concentration and variant allele fraction, into an absolute number of target molecules in a sample [@problem_id:5100398]. By performing this fundamental calculation, you will gain a concrete appreciation for the molecular rarity of ctDNA and the sensitivity required of diagnostic assays.", "problem": "In circulating tumor DNA (ctDNA)-based cancer monitoring, the variant allele fraction (AF) is defined as the fraction of locus-specific deoxyribonucleic acid molecules that harbor a specific somatic mutation among all locus-specific molecules present in the sample. Consider a plasma sample of volume $10$ mL with a measured cell-free deoxyribonucleic acid (cfDNA) concentration of $20$ ng/mL. Assume that the typical cfDNA fragment length is approximately $166$ base pairs, but for the purpose of counting locus copies, use the standard conversion that $3.3$ pg of deoxyribonucleic acid corresponds to one human haploid genome equivalent. Assume a single-copy locus per haploid genome, that recovery and assay sampling are unbiased with respect to allele identity, and that ploidy alterations can be neglected so that AF reflects the fraction of haploid genome equivalents carrying the mutant allele at that locus. The plasma variant allele fraction is $AF = 0.002$.\n\nStarting only from the definitions of AF as a fraction of locus copies and the mass-to-copy conversion based on the haploid genome mass, derive an expression for the expected number of mutant molecules in the entire $10$ mL plasma volume and evaluate it numerically.\n\nRound your final answer to three significant figures and report it in molecules (use “molecules” as the unit in your reasoning; the final numeric answer should be unitless).", "solution": "The objective is to derive an expression for and calculate the expected number of mutant DNA molecules in a given plasma sample. Let $N_{mutant}$ be this number.\n\nThe givens are:\n- Plasma sample volume, $V = 10 \\text{ mL}$.\n- cfDNA concentration, $C = 20 \\text{ ng/mL}$.\n- Mass per haploid genome equivalent, $M_{HGE} = 3.3 \\text{ pg}$.\n- Variant allele fraction, $AF = 0.002$.\n\nThe problem defines the variant allele fraction ($AF$) as the ratio of mutant molecules to the total number of locus-specific molecules. Assuming a single-copy locus per haploid genome and no ploidy alterations, the total number of locus-specific molecules, $N_{total}$, is equal to the total number of haploid genome equivalents in the sample.\n\n$$AF = \\frac{N_{mutant}}{N_{total}}$$\nFrom this definition, the expression for the number of mutant molecules is:\n$$N_{mutant} = AF \\times N_{total}$$\n\nTo find $N_{total}$, we must first determine the total mass of cfDNA in the sample, $M_{total}$, and then convert this mass into the number of haploid genome equivalents.\n\nStep 1: Calculate the total mass of cfDNA ($M_{total}$).\nThe total mass is the product of the concentration and the volume:\n$$M_{total} = C \\times V$$\nSubstituting the given values:\n$$M_{total} = (20 \\text{ ng/mL}) \\times (10 \\text{ mL}) = 200 \\text{ ng}$$\n\nStep 2: Convert the total mass to the total number of haploid genome equivalents ($N_{total}$).\nThe mass per haploid genome equivalent is given in picograms ($pg$), so we must convert $M_{total}$ from nanograms ($ng$) to picograms. The conversion is $1 \\text{ ng} = 10^3 \\text{ pg}$.\n$$M_{total} = 200 \\text{ ng} \\times \\frac{10^3 \\text{ pg}}{1 \\text{ ng}} = 200 \\times 10^3 \\text{ pg} = 2 \\times 10^5 \\text{ pg}$$\nThe total number of haploid genome equivalents (which corresponds to the total number of locus-specific molecules) is the total mass divided by the mass per equivalent:\n$$N_{total} = \\frac{M_{total}}{M_{HGE}}$$\nSubstituting the values:\n$$N_{total} = \\frac{2 \\times 10^5 \\text{ pg}}{3.3 \\text{ pg/molecule}}$$\nNote that \"molecule\" here is used synonymously with \"haploid genome equivalent\" or \"locus copy\" as per the problem's context.\n\nStep 3: Derive the full expression for $N_{mutant}$ and calculate its value.\nBy substituting the expression for $N_{total}$ into the equation for $N_{mutant}$, we obtain the complete derived expression:\n$$N_{mutant} = AF \\times \\frac{C \\times V}{M_{HGE}}$$\nNow, we can evaluate this expression numerically. It is equivalent to substituting the calculated $N_{total}$ into the earlier equation for $N_{mutant}$:\n$$N_{mutant} = AF \\times N_{total} = 0.002 \\times \\frac{2 \\times 10^5}{3.3} \\text{ molecules}$$\n$$N_{mutant} = \\frac{400}{3.3} \\text{ molecules} \\approx 121.2121... \\text{ molecules}$$\nThe problem requires the final answer to be rounded to three significant figures.\n$$N_{mutant} \\approx 121 \\text{ molecules}$$\nThus, the expected number of mutant molecules in the entire $10 \\text{ mL}$ plasma volume is $121$.", "answer": "$$\\boxed{121}$$", "id": "5100398"}, {"introduction": "Detecting the rare mutant molecules quantified in the previous exercise is a significant statistical challenge governed by the principles of random sampling. This practice delves into the design of a liquid biopsy assay, using the Poisson distribution to model the probability of capturing ctDNA molecules from a plasma sample [@problem_id:5100349]. By deriving the relationship between input DNA mass and detection sensitivity, you will understand the fundamental trade-offs that dictate an assay's limit of detection.", "problem": "A liquid biopsy assay is used to monitor circulating tumor DNA (ctDNA) in plasma. A sequencing library is prepared from cell-free DNA (cfDNA) extracted from plasma. Let the total cfDNA mass input to the library be $M$ in nanograms, and let the combined molecular recovery fraction (product of pre-analytical recovery and library conversion efficiency) be $\\rho$ (unitless). Assume the human diploid genome mass is $m_g = 6.6$ picograms per genome equivalent, and that mutant molecules are present at a fraction $p$ of genome equivalents in the cfDNA. Assume molecules are sampled independently.\n\nStarting from the definition of the Binomial distribution for independent sampling and its Poisson limit for large $N$ and small $p$ with finite $Np$, derive an expression for the probability of capturing at least one mutant molecule as a function of $M$, $\\rho$, $p$, and $m_g$. Use this expression to solve for the minimal cfDNA input mass $M$ (in nanograms) required to achieve a capture probability of at least $0.95$ for the parameter values $\\rho = 0.40$ and $p = 5.0 \\times 10^{-4}$.\n\nExpress the final numeric answer for $M$ in nanograms and round to three significant figures.", "solution": "The first step is to determine the total number of genome equivalents (GE) that are successfully captured and available for sequencing. The input mass $M$ is given in nanograms (ng), while the mass per diploid genome, $m_g$, is given in picograms (pg). Harmonizing units, $1 \\text{ ng} = 10^3 \\text{ pg}$, so the input mass in picograms is $10^3 M$.\n\nThe number of diploid genome equivalents in the initial sample is the total mass divided by the mass per diploid genome:\n$$N_{\\text{initial}} = \\frac{10^3 M}{m_g}$$\nwhere $M$ is in nanograms and $m_g$ is in picograms. The combined molecular recovery fraction, $\\rho$, represents the efficiency of all steps leading to the final sequencing library. The number of genome equivalents successfully captured in the library, $N$, is:\n$$N = \\rho N_{\\text{initial}} = \\frac{10^3 \\rho M}{m_g}$$\nThis value $N$ represents the total number of independent trials in our sampling experiment. A subtle point is whether to count haploid or diploid genome equivalents. While using haploid equivalents is more rigorous for allele-level calculations, the convention for this type of assay sensitivity modeling often uses diploid genome equivalents, implicitly assuming that one \"genome equivalent\" by mass contains, on average, one copy of any given locus. Given the problem phrasing, we will adopt this common interpretation.\n\nWe are interested in the number of mutant molecules, $X$, captured in the library. Each of the $N$ captured molecules has a probability $p$ of being a mutant. This scenario follows a Binomial distribution, $X \\sim \\text{Binomial}(n=N, p)$. For large $N$ and small $p$, as is typical in ctDNA analysis, this can be approximated by a Poisson distribution with parameter $\\lambda = Np$, which represents the expected number of mutant molecules captured.\n$$\\lambda = Np = \\left( \\frac{10^3 \\rho M}{m_g} \\right) p$$\n\nThe probability of observing exactly $k$ mutant molecules under the Poisson model is $P(X=k) = \\frac{\\lambda^k e^{-\\lambda}}{k!}$. We need to find the probability of capturing at least one mutant molecule, $P(X \\ge 1)$. It is simpler to calculate the complement, the probability of capturing zero mutant molecules, $P(X=0)$, and subtract it from $1$.\n$$P(X \\ge 1) = 1 - P(X=0) = 1 - \\frac{\\lambda^0 e^{-\\lambda}}{0!} = 1 - e^{-\\lambda}$$\nSo, the derived expression for the capture probability is:\n$$P(X \\ge 1) = 1 - \\exp\\left( -\\frac{10^3 \\rho M p}{m_g} \\right)$$\n\nWe are tasked with finding the minimal mass $M$ required to achieve a capture probability of at least $0.95$:\n$$1 - \\exp\\left( -\\frac{10^3 \\rho M p}{m_g} \\right) \\ge 0.95$$\nRearranging the inequality:\n$$\\exp\\left( -\\frac{10^3 \\rho M p}{m_g} \\right) \\le 1 - 0.95 = 0.05$$\nTaking the natural logarithm of both sides and multiplying by $-1$ (which reverses the inequality):\n$$\\frac{10^3 \\rho M p}{m_g} \\ge -\\ln(0.05) = \\ln\\left(\\frac{1}{0.05}\\right) = \\ln(20)$$\nNow, we solve for $M$:\n$$M \\ge \\frac{m_g \\ln(20)}{10^3 \\rho p}$$\nThe minimal mass $M_{\\text{min}}$ is given by the equality. We substitute the given numerical values: $m_g = 6.6$ pg, $\\rho = 0.40$, $p = 5.0 \\times 10^{-4}$, and $\\ln(20) \\approx 2.99573$.\n$$M_{\\text{min}} = \\frac{6.6 \\times \\ln(20)}{1000 \\times 0.40 \\times (5.0 \\times 10^{-4})}$$\n$$M_{\\text{min}} = \\frac{6.6 \\times \\ln(20)}{0.2} = 33 \\times \\ln(20)$$\n$$M_{\\text{min}} \\approx 33 \\times 2.99573 \\approx 98.8591$$\nThe unit of $M$ is nanograms. Rounding the result to three significant figures gives $98.9$.", "answer": "$$\\boxed{98.9}$$", "id": "5100349"}, {"introduction": "Once a ctDNA variant is detected and its allele fraction ($AF$) is measured, the next crucial step is to interpret this value in the context of the patient's tumor burden. This exercise moves beyond simple detection to quantitative interpretation, demonstrating how tumor-specific genetic features like copy number alterations affect the observed $AF$ [@problem_id:5100362]. By deriving and applying a more sophisticated model that relates $AF$ to the tumor fraction ($\\tau$), you will learn how to generate a more accurate estimate of tumor burden from sequencing data.", "problem": "A plasma sample for cancer monitoring contains a mixture of circulating tumor deoxyribonucleic acid (ctDNA) and circulating normal cell-free deoxyribonucleic acid (cfDNA). Let the tumor fraction be $\\tau$, defined as the fraction of cfDNA molecules originating from tumor cells. At a locus with a somatic single nucleotide variant (present only in tumor), the tumor genome has $c_t$ total chromosomal copies at that locus (absolute copy number) and $c_m$ copies carry the mutant allele. The normal cfDNA contribution is assumed diploid with $2$ copies at the locus and no mutant allele. Sequencing reads are sampled uniformly and independently from alleles present in the cfDNA mixture, such that the expected observed variant allele fraction (AF), denoted $AF$, equals the probability that a randomly sampled allele molecule from the mixture is mutant.\n\nStarting from these foundational facts and definitions:\n- Allele counts in cfDNA are proportional to copy number and cfDNA source fraction.\n- The expected observed variant allele fraction $AF$ is the ratio of mutant-allele molecules to the total-allele molecules in the mixture.\n\nDerive from first principles the expression for $AF$ as a function of $\\tau$, $c_m$, and $c_t$ under these assumptions. Then algebraically solve for $\\tau$ in terms of $AF$, $c_m$, and $c_t$, and evaluate $\\tau$ for a sample in which copy-number profiling reports $c_t = 3$ and $c_m = 1$, and the sequencing shows $AF = 0.070$ at this locus. Express the final numerical value of $\\tau$ as a unitless fraction and round your answer to four significant figures.", "solution": "Let us define the relative contributions of alleles from the tumor and normal cell-free DNA (cfDNA) pools to the total cfDNA mixture in the plasma. The problem states that allele counts are proportional to the copy number at the locus and the fraction of cfDNA from the source.\n\nThe tumor fraction is given as $\\tau$. This means that a fraction $\\tau$ of the cfDNA molecules originates from tumor cells, and the remaining fraction, $1-\\tau$, originates from normal (non-tumor) cells.\n\nLet's consider the relative abundance of the mutant allele.\nThe mutant allele is present only in the tumor-derived cfDNA. Within the tumor genome, there are $c_m$ copies of the mutant allele out of a total of $c_t$ copies at that locus. The contribution of mutant alleles to the total pool of alleles in the plasma is therefore proportional to the tumor fraction multiplied by the number of mutant alleles per tumor cell genome.\nLet $N_m$ be the relative abundance of mutant alleles.\n$$N_m \\propto \\tau \\cdot c_m$$\nThe normal cells are diploid and do not carry the mutation, so their contribution to the mutant allele count is $0$.\n\nNext, let's consider the relative abundance of all alleles (mutant and wild-type) at this locus from all sources.\nThe tumor-derived cfDNA contributes a total of $c_t$ alleles per genome. Its contribution to the total allele pool is proportional to $\\tau \\cdot c_t$.\nThe normal-derived cfDNA is diploid, contributing $2$ alleles per genome. Its contribution to the total allele pool is proportional to $(1-\\tau) \\cdot 2$.\nLet $N_{total}$ be the total relative abundance of all alleles at the locus.\n$$N_{total} \\propto \\tau \\cdot c_t + (1-\\tau) \\cdot 2$$\n\nThe expected variant allele fraction, $AF$, is defined as the ratio of mutant-allele molecules to total-allele molecules. Using the proportional abundances:\n$$AF = \\frac{N_m}{N_{total}} = \\frac{\\tau c_m}{\\tau c_t + 2(1-\\tau)}$$\nThis is the expression for $AF$ as a function of $\\tau$, $c_m$, and $c_t$, derived from first principles as requested.\n\nThe second part of the task is to solve this equation for the tumor fraction, $\\tau$.\nWe start with the derived expression:\n$$AF = \\frac{\\tau c_m}{\\tau c_t + 2 - 2\\tau}$$\nTo solve for $\\tau$, we first multiply both sides by the denominator:\n$$AF (\\tau c_t + 2 - 2\\tau) = \\tau c_m$$\nDistribute $AF$ on the left-hand side:\n$$AF \\cdot \\tau c_t + 2AF - 2AF \\cdot \\tau = \\tau c_m$$\nNow, we gather all terms containing $\\tau$ on one side of the equation and all other terms on the opposite side.\n$$2AF = \\tau c_m - AF \\cdot \\tau c_t + 2AF \\cdot \\tau$$\nFactor out $\\tau$ from the terms on the right-hand side:\n$$2AF = \\tau (c_m - AF c_t + 2AF)$$\nThis can be rearranged slightly to group the terms involving $AF$:\n$$2AF = \\tau (c_m + AF(2 - c_t))$$\nFinally, we isolate $\\tau$ by dividing by its coefficient:\n$$\\tau = \\frac{2AF}{c_m + AF(2 - c_t)}$$\nThis is the expression for $\\tau$ in terms of $AF$, $c_m$, and $c_t$.\n\nThe final part of the task is to evaluate $\\tau$ for the given values:\n- Absolute copy number in tumor, $c_t = 3$\n- Mutant allele copy number in tumor, $c_m = 1$\n- Observed variant allele fraction, $AF = 0.070$\n\nWe substitute these numerical values into the expression for $\\tau$:\n$$\\tau = \\frac{2(0.070)}{1 + (0.070)(2 - 3)}$$\nFirst, calculate the term in the parenthesis:\n$$\\tau = \\frac{2(0.070)}{1 + (0.070)(-1)}$$\n$$\\tau = \\frac{0.140}{1 - 0.070}$$\n$$\\tau = \\frac{0.140}{0.930}$$\nPerforming the division gives:\n$$\\tau \\approx 0.150537634...$$\nThe problem requires the answer to be rounded to four significant figures.\nThe first four significant figures are $1$, $5$, $0$, and $5$. The fifth significant figure is $3$, which is less than $5$, so we round down.\n$$\\tau \\approx 0.1505$$\nThus, the estimated tumor fraction in the sample is $0.1505$.", "answer": "$$\\boxed{0.1505}$$", "id": "5100362"}]}